Skip to main content

Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies

Publication ,  Journal Article
Arora, J; Sauer, SJ; Tarpley, M; Vermeulen, P; Rypens, C; Van Laere, S; Williams, KP; Devi, GR; Dewhirst, MW
Published in: ONCOTARGET
April 18, 2017

Duke Scholars

Published In

ONCOTARGET

EISSN

1949-2553

Publication Date

April 18, 2017

Volume

8

Issue

16

Start / End Page

25848 / 25863

Publisher

IMPACT JOURNALS LLC

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Arora, J., Sauer, S. J., Tarpley, M., Vermeulen, P., Rypens, C., Van Laere, S., … Dewhirst, M. W. (2017). Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies. ONCOTARGET, 8(16), 25848–25863.
Arora, Jay, Scott J. Sauer, Michael Tarpley, Peter Vermeulen, Charlotte Rypens, Steven Van Laere, Kevin P. Williams, Gayathri R. Devi, and Mark W. Dewhirst. “Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.” ONCOTARGET 8, no. 16 (April 18, 2017): 25848–63.
Arora J, Sauer SJ, Tarpley M, Vermeulen P, Rypens C, Van Laere S, Williams KP, Devi GR, Dewhirst MW. Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies. ONCOTARGET. IMPACT JOURNALS LLC; 2017 Apr 18;8(16):25848–25863.

Published In

ONCOTARGET

EISSN

1949-2553

Publication Date

April 18, 2017

Volume

8

Issue

16

Start / End Page

25848 / 25863

Publisher

IMPACT JOURNALS LLC

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis